1af3:A (SER4) to (LEU194) RAT BCL-XL AN APOPTOSIS INHIBITORY PROTEIN | BCL-XL, APOPTOSIS, MITOCHONDRION, ALTERNATIVE SPLICING, REGULATORY PROTEIN
4wmu:A (LEU174) to (HIS320) STRUCTURE OF MBP-MCL1 BOUND TO LIGAND 2 AT 1.55A | APOPTOSIS, PROTEIN-PROTEIN INTERACTION
4hw4:B (GLY203) to (PHE319) DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN | ANTI-APOPTOTIC PROTEIN, BH3 PEPTIDES, APOPTOSIS
2pqk:A (LEU174) to (HIS320) X-RAY CRYSTAL STRUCTURE OF HUMAN MCL-1 IN COMPLEX WITH BIM BH3 | BCL-2 FAMILY, BH3 DOMAIN, APOPTOSIS
3spf:A (GLN3) to (LEU194) CRYSTAL STRUCTURE OF BCL-XL BOUND TO BM501 | BCL-2-LIKE PROTEIN, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX, APOPTOSIS REGULATOR-INHIBITOR COMPLEX
1pq0:A (SER2) to (LEU194) CRYSTAL STRUCTURE OF MOUSE BCL-XL | BCL-XL, APOPTOSIS
2roc:A (ASP154) to (VAL302) SOLUTION STRUCTURE OF MCL-1 COMPLEXED WITH PUMA | MCL-1, BCL-2, APOPTOSIS, PUMA, BH3-ONLY, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION
2rod:A (GLU152) to (ASP304) SOLUTION STRUCTURE OF MCL-1 COMPLEXED WITH NOXAA | MCL-1, NOXAA, APOPTOSIS, BH3-ONLY, BCL-2, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, TRANSMEMBRANE, UBL CONJUGATION
1r2d:A (GLN3) to (LEU194) STRUCTURE OF HUMAN BCL-XL AT 1.95 ANGSTROMS | APOPTOSIS, MONOMERIC, ALPHA-HELICAL
1r2e:A (SER2) to (LEU194) HUMAN BCL-XL CONTAINING A GLU TO LEU MUTATION AT POSITION 92 | APOPTOSIS, MONOMERIC, ALPHA-HELICAL, MUTATION
1r2g:A (SER2) to (LEU194) HUMAN BCL-XL CONTAINING A PHE TO TRP MUTATION AT POSITION 97 | APOPTOSIS, MONOMERIC, ALPHA-HELICAL, MUTATION
1r2i:A (GLN3) to (LEU194) HUMAN BCL-XL CONTAINING A PHE TO LEU MUTATION AT POSITION 146 | APOPTOSIS, MONOMERIC, ALPHA-HELICAL, MUTATION
4k5a:A (ASP20) to (LEU161) CO-CRYSTALLIZATION WITH CONFORMATION-SPECIFIC DESIGNED ANKYRIN REPEAT PROTEINS EXPLAINS THE CONFORMATIONAL FLEXIBILITY OF BCL-W | APOPTOSIS, ANTI-APOPTOTIC BCL-2 FAMILY, BCL-W;CRYSTAL STRUCTURE, LIGAND BINDING-COMPETENT CONFORMATION, DARPINS
4zbi:A (GLY203) to (HIS320) MCL-1 COMPLEXED WITH SMALL MOLECULES | INHIBITOR, COMPLEX
4zbi:C (GLY203) to (PHE319) MCL-1 COMPLEXED WITH SMALL MOLECULES | INHIBITOR, COMPLEX
2vm6:A (SER0) to (GLU149) HUMAN BCL2-A1 IN COMPLEX WITH BIM-BH3 PEPTIDE | B-CELL LYMPHOMA2, ANTIAPOPTOTIC, IMMUNE SYSTEM, BIM, BFL-1, BCL2A1, BCL-2A1, MEMBRANE, APOPTOSIS
2vof:A (SER0) to (GLU149) STRUCTURE OF MOUSE A1 BOUND TO THE PUMA BH3-DOMAIN | BH3, BCL-2, APOPTOSIS, PRO-SURVIVAL, MITOCHONDRION, PROTEIN-PROTEIN COMPLEX
2voi:A (SER0) to (PHE148) STRUCTURE OF MOUSE A1 BOUND TO THE BID BH3-DOMAIN | PROTEIN-PROTEIN COMPLEX, BH3, BCL-2, MEMBRANE, APOPTOSIS, PRO-SURVIVAL, MITOCHONDRION, PHOSPHOPROTEIN
2vog:A (MET1) to (GLU149) STRUCTURE OF MOUSE A1 BOUND TO THE BMF BH3-DOMAIN | PROTEIN-PROTEIN COMPLEX, BH3, BCL-2, APOPTOSIS, PRO-SURVIVAL
2voh:A (MET1) to (PHE148) STRUCTURE OF MOUSE A1 BOUND TO THE BAK BH3-DOMAIN | BH3, BCL-2, MEMBRANE, APOPTOSIS, PRO-SURVIVAL, TRANSMEMBRANE, PROTEIN-PROTEIN COMPLEX
3ihc:A (SER2) to (LEU194) CRYSTAL STRUCTURE OF MOUSE BCL-XL (WT) AT PH 5.0 | APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE
3ihd:A (HIS0) to (TYR195) CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (Y101A) AT PH 5.0 | APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE
3ihe:A (GLN3) to (LEU194) CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (F105A) AT PH 6.0 | APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE
3ihf:A (SER4) to (LEU194) CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (R139A) AT PH 5.0 | APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE
3ihf:B (GLN3) to (LEU194) CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (R139A) AT PH 5.0 | APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE
3ihf:C (SER4) to (TYR195) CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (R139A) AT PH 5.0 | APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE
3ihf:D (GLN3) to (TYR195) CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (R139A) AT PH 5.0 | APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE
3iig:A (GLN3) to (LEU194) CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (F105A) AT PH 5.0 | APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE
3iih:A (SER2) to (LEU194) CRYSTAL STRUCTURE OF MOUSE BCL-XL (WT) AT PH 6.0 | APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE
3ilc:A (HIS0) to (LEU194) CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (Y101A) AT PH 6.0 | APOPTOSIS, BH3 DOMAIN, BCL-2, ALTERNATIVE SPLICING, CYTOPLASM, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE
3io9:A (ASP172) to (PHE319) BIML12Y IN COMPLEX WITH MCL-1 | APOPTOSIS, ALTERNATIVE SPLICING, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, ISOPEPTIDE BOND, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION
1ty4:A (ILE80) to (ARG237) CRYSTAL STRUCTURE OF A CED-9/EGL-1 COMPLEX | APOPTOSIS, CED-9, EGL-1, BCL-2 FAMILY PROTEINS, RECOGNITION
4lvt:A (ASN9) to (TYR199) BCL_2-NAVITOCLAX (ABT-263) COMPLEX | 8 HELICES, APOPTOSIS REGULATOR-INHIBITOR COMPLEX
4lvt:B (ASN9) to (TYR199) BCL_2-NAVITOCLAX (ABT-263) COMPLEX | 8 HELICES, APOPTOSIS REGULATOR-INHIBITOR COMPLEX
4lxd:A (ASN9) to (LEU198) BCL_2-NAVITOCLAX ANALOG (WITHOUT THIOPHENYL) COMPLEX | 8 HELICES, APOPTOSIS REGULATOR-INHIBITOR COMPLEX
5agw:B (GLU13) to (TYR202) BCL-2 ALPHA BETA-1 COMPLEX | BCL-2, FOLDAMER, BIM, APOPTOSIS
3wiy:A (LEU174) to (PHE319) CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 10 | REGULATION, APOPTOSIS
3wiy:C (GLU173) to (PHE319) CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 10 | REGULATION, APOPTOSIS
3wiy:E (GLY203) to (PHE319) CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 10 | REGULATION, APOPTOSIS
3wiy:F (GLU173) to (HIS320) CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 10 | REGULATION, APOPTOSIS
2jm6:B (GLU152) to (PHE299) SOLUTION STRUCTURE OF MCL-1 COMPLEXED WITH NOXAB | APOPTOSIS, MCL-1, BCL-2, HELICAL BUNDLE, BH3-ONLY
2k7w:A (GLU17) to (TYR164) BAX ACTIVATION IS INITIATED AT A NOVEL INTERACTION SITE | BAX, BIM, BH3, BCL-2, APOPTOSIS
2kua:A (LEU8) to (LYS159) SOLUTION STRUCTURE OF A DIVERGENT BCL-2 PROTEIN | BOO, DIVA, BCL-2, APOPTOSIS, BH3-ONLY, MEMBRANE, MITOCHONDRION, NUCLEUS, TRANSMEMBRANE
1wsx:A (LEU155) to (PHE299) SOLUTION STRUCTURE OF MCL-1 | HELICAL BUNDLE, APOPTOSIS, BCL-2, BH3, MCL-1
2lpc:A (GLN3) to (TYR155) NMR STRUCTURE OF BCL-XL | APOPTOSIS, APOPTOSIS INHIBITOR
5c3f:A (SER172) to (HIS320) CRYSTAL STRUCTURE OF MCL-1 BOUND TO BID-MM | COMPLEX, BCL-2 FAMILY, BH3, STAPLED PEPTIDE, APOPTOSIS
2lr1:A (GLU17) to (PHE165) STRUCTURAL MECHANISM FOR BAX INHIBITION BY CYTOMEGALOVIRUS PROTEIN VMIA | APOPTOSIS-SIGNALING PROTEIN COMPLEX
2mhs:A (ASP3) to (HIS151) NMR STRUCTURE OF HUMAN MCL-1 | MCL-1, BCL-2 FAMILY, BH DOMAIN, APOPTOSIS, CANCER DRUG, GFT NMR
5c6h:G (GLY203) to (HIS320) MCL-1 COMPLEXED WITH MULE | COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX
5c6h:I (ASP172) to (HIS320) MCL-1 COMPLEXED WITH MULE | COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX
5c6h:K (SER202) to (HIS320) MCL-1 COMPLEXED WITH MULE | COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX
5c6h:M (GLY203) to (HIS320) MCL-1 COMPLEXED WITH MULE | COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX
5c6h:O (ALA204) to (HIS320) MCL-1 COMPLEXED WITH MULE | COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX
5c6h:Q (SER206) to (HIS320) MCL-1 COMPLEXED WITH MULE | COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX
5c6h:S (GLU173) to (PHE319) MCL-1 COMPLEXED WITH MULE | COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX
5c6h:W (ASP172) to (HIS320) MCL-1 COMPLEXED WITH MULE | COMPLEX. MCL-1, MULE, BH3, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX
2nl9:A (ASP172) to (PHE319) CRYSTAL STRUCTURE OF THE MCL-1:BIM BH3 COMPLEX | APOPTOSIS, BCL-2, MCL-1, BIM
2nla:A (ASP172) to (HIS320) CRYSTAL STRUCTURE OF THE MCL-1:MNOXAB BH3 COMPLEX | APOPTOSIS, BCL-2, MCL-1, NOXA
2yxj:B (SER4) to (LEU194) CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH ABT-737 | APOPTOSIS, CANCER THERAPEUTIC
2o2m:A (GLN7) to (LEU198) SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-XL IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND | APOPTOSIS, COMPLEX, BCL, NMR
4oq5:E (MET172) to (PHE319) CRYSTAL STRUCTURE OF HUMAN MCL-1 BOUND TO INHIBITOR 4-(4- METHYLNAPHTHALEN-1-YL)-2-{[(4-PHENOXYPHENYL)SULFONYL]AMINO}BENZOIC ACID | APOPTOSIS-INHIBITOR COMPLEX
1maz:A (MET1) to (LEU194) X-RAY STRUCTURE OF BCL-XL, AN INHIBITOR OF PROGRAMMED CELL DEATH | APOPTOSIS, PROGRAMMED CELL DEATH, BCL-2 FAMILY
3kj0:A (SER202) to (HIS320) MCL-1 IN COMPLEX WITH BIM BH3 MUTANT I2DY | BCL-2, BH3, APOPTOSIS, PROTEIN-PEPTIDE COMPLEX, ALTERNATIVE SPLICING, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, ISOPEPTIDE BOND, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION
3kj2:A (GLY203) to (HIS320) MCL-1 IN COMPLEX WITH BIM BH3 MUTANT F4AE | BCL-2, BH3, APOPTOSIS, PROTEIN-PEPTIDE COMPLEX, ALTERNATIVE SPLICING, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, ISOPEPTIDE BOND, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION
3kz0:A (GLY203) to (HIS320) MCL-1 COMPLEX WITH MCL-1-SPECIFIC SELECTED PEPTIDE | BCL-2, BH3, MITOCHONDRION, APOPTOSIS, ANTI-APOPTOTIC
1ysw:A (ASP8) to (GLY200) SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2 COMPLEXED WITH AN ACYL-SULFONAMIDE-BASED LIGAND | COMPLEX, APOPTOSIS
4aq3:A (ASN11) to (TYR161) HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR | APOPTOSIS, CHIMERA
4aq3:D (ASP10) to (TYR161) HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR | APOPTOSIS, CHIMERA
4aq3:E (ASN11) to (LEU160) HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR | APOPTOSIS, CHIMERA
4aq3:F (ASP10) to (GLY162) HUMAN BCL-2 WITH PHENYLACYLSULFONAMIDE INHIBITOR | APOPTOSIS, CHIMERA
4qnq:A (SER2) to (ASN197) CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH BCL-XL IN COMPLEX WITH THE INHIBITOR ABT-263 | ALPHA-HELICAL PROTEIN,APOPTOSIS, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX
4qnq:E (MET1) to (GLY196) CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH BCL-XL IN COMPLEX WITH THE INHIBITOR ABT-263 | ALPHA-HELICAL PROTEIN,APOPTOSIS, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX
4qnq:I (MET1) to (GLY196) CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH BCL-XL IN COMPLEX WITH THE INHIBITOR ABT-263 | ALPHA-HELICAL PROTEIN,APOPTOSIS, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX
4qnq:J (GLN3) to (ASN197) CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH BCL-XL IN COMPLEX WITH THE INHIBITOR ABT-263 | ALPHA-HELICAL PROTEIN,APOPTOSIS, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX
4qnq:L (MET1) to (TYR195) CRYSTAL STRUCTURE ANALYSIS OF FULL-LENGTH BCL-XL IN COMPLEX WITH THE INHIBITOR ABT-263 | ALPHA-HELICAL PROTEIN,APOPTOSIS, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX
3mk8:A (ASP172) to (HIS320) THE MCL-1 BH3 HELIX IS AN EXCLUSIVE MCL-1 INHIBITOR AND APOPTOSIS SENSITIZER | MCL-1, MCL-1 SAHB D, STAPLE, SAHB, BCL-2 FAMILY, APOPTOSIS, ANTI- APOPTOTIC, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX
4bpi:A (ASP172) to (PHE319) MCL-1 BOUND TO ALPHA BETA PUMA BH3 PEPTIDE 2 | APOPTOSIS, CHIMERA, BIM
4bpj:A (ASP172) to (PHE319) MCL-1 BOUND TO ALPHA BETA PUMA BH3 PEPTIDE 3 | APOPTOSIS, CHIMERA, BIM
5fdr:A (GLY203) to (HIS320) MCL-1 COMPLEXED WITH SMALL MOLECULE INHIBITOR | MCL-1, INHIBITOR, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX
5fdr:C (ASP172) to (PHE319) MCL-1 COMPLEXED WITH SMALL MOLECULE INHIBITOR | MCL-1, INHIBITOR, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX
4s0o:B (SER15) to (GLY166) CRYSTAL STRUCTURE OF THE AUTOINHIBITED DIMER OF PRO-APOPTOTIC BAX (I) | BCL-2 FAMILY PROTEIN, APOPTOSIS REGULATOR, AUTOINHIBITED DIMER, APOPTOSIS
3d7v:A (ASP172) to (HIS320) CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH AN MCL-1 SELECTIVE BH3 LIGAND | HELICAL BUNDLE, AMPHIPATHIC HELIX, ALTERNATIVE SPLICING, APOPTOSIS, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION
3pk1:A (SER173) to (PHE319) CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH THE BAXBH3 DOMAIN | BCL-2 FAMILY FOLD, REGULATION OF APOPTOSIS, BAX, MITOCHONDRIA, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX
3pk1:C (SER173) to (PHE319) CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH THE BAXBH3 DOMAIN | BCL-2 FAMILY FOLD, REGULATION OF APOPTOSIS, BAX, MITOCHONDRIA, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX
3pl7:A (SER4) to (LEU194) CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH THE BAXBH3 DOMAIN | BCL-2 FAMILY FOLD, REGULATION OF APOPTOSIS, BAX, MITOCHONDRIA, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX
3pl7:B (SER4) to (TYR195) CRYSTAL STRUCTURE OF BCL-XL IN COMPLEX WITH THE BAXBH3 DOMAIN | BCL-2 FAMILY FOLD, REGULATION OF APOPTOSIS, BAX, MITOCHONDRIA, APOPTOSIS-APOPTOSIS REGULATOR COMPLEX
5jsb:A (GLU173) to (PHE319) CRYSTAL STRUCTURE OF MCL1-INHIBITOR COMPLEX | MCL-1, ANTIMCL1, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX
5jsb:C (THR205) to (PHE319) CRYSTAL STRUCTURE OF MCL1-INHIBITOR COMPLEX | MCL-1, ANTIMCL1, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX
5jsb:E (SER202) to (PHE319) CRYSTAL STRUCTURE OF MCL1-INHIBITOR COMPLEX | MCL-1, ANTIMCL1, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX
5jsb:G (LEU174) to (PHE319) CRYSTAL STRUCTURE OF MCL1-INHIBITOR COMPLEX | MCL-1, ANTIMCL1, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX
5jsb:I (GLU173) to (PHE319) CRYSTAL STRUCTURE OF MCL1-INHIBITOR COMPLEX | MCL-1, ANTIMCL1, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX
5jsb:K (ASP172) to (PHE319) CRYSTAL STRUCTURE OF MCL1-INHIBITOR COMPLEX | MCL-1, ANTIMCL1, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX
5lof:A (LEU174) to (HIS320) CRYSTAL STRUCTURE OF THE MBP-MCL1 COMPLEX WITH HIGHLY SELECTIVE AND POTENT INHIBITOR OF MCL1 | APOPTOSIS-INHIBITOR COMPLEX, MCL-1, S S63845, MBP
4wmv:A (LEU174) to (HIS320) STRUCTURE OF MBP-MCL1 BOUND TO LIGAND 4 AT 2.4A | APOPTOSIS, PROTEIN-PROTEIN INTERACTION
4hw2:D (GLU173) to (PHE319) DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN | REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX
4hw2:E (GLY171) to (PHE319) DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN | REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX
4hw2:F (GLU173) to (HIS320) DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN | REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX
4hw3:H (ASP172) to (PHE319) DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN | REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX
4hw3:I (LEU174) to (HIS320) DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN | REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX
4hw3:J (GLU173) to (HIS320) DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN | REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX
4hw3:K (GLU173) to (VAL321) DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN | REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX
4hw3:L (GLU173) to (PHE319) DISCOVERY OF POTENT MCL-1 INHIBITORS USING FRAGMENT-BASED METHODS AND STRUCTURE-BASED DESIGN | REGULATION OF APOPTOSIS, MAINTENANCE OF VIABILITY, APOPTOSIS, APOPTOSIS-INHIBITOR COMPLEX
1r2h:A (MET1) to (LEU194) HUMAN BCL-XL CONTAINING AN ALA TO LEU MUTATION AT POSITION 142 | APOPTOSIS, MONOMERIC, ALPHA-HELICAL, MUTATION
4zbf:H (GLU173) to (PHE319) MCL-1 COMPLEXED WITH SMALL MOLECULES | INHIBITOR, COMPLEX
3ilb:N (GLN3) to (LEU194) CRYSTAL STRUCTURE OF MOUSE BCL-XL MUTANT (R139A) AT PH 6.0 | APOPTOSIS, BH3 DOMAIN, BCL-2, MEMBRANE, MITOCHONDRION, TRANSMEMBRANE
4man:B (ASN9) to (LEU198) BCL_2-NAVITOCLAX ANALOG (WITH INDOLE) COMPLEX | 8 HELICES, APOPTOSIS REGULATOR-INHIBITOR COMPLEX
3wix:D (GLY203) to (PHE319) CRYSTAL STRUCTURE OF MCL-1 IN COMPLEX WITH COMPOUND 4 | REGULATION, APOPTOSIS
2kbw:A (GLU173) to (PHE319) SOLUTION STRUCTURE OF HUMAN MCL-1 COMPLEXED WITH HUMAN BID_BH3 PEPTIDE | MCL-1, BID_BH3, COMPLEX, ALTERNATIVE SPLICING, APOPTOSIS, CYTOPLASM, DEVELOPMENTAL PROTEIN, DIFFERENTIATION, MEMBRANE, MITOCHONDRION, NUCLEUS, PHOSPHOPROTEIN, POLYMORPHISM, TRANSMEMBRANE, UBL CONJUGATION
2o21:A (ASP8) to (GLY200) SOLUTION STRUCTURE OF THE ANTI-APOPTOTIC PROTEIN BCL-2 IN COMPLEX WITH AN ACYL-SULFONAMIDE-BASED LIGAND | APOPTOSIS, COMPLEX, BCL, NMR
3mqp:A (GLY7) to (GLU149) CRYSTAL STRUCTURE OF HUMAN BFL-1 IN COMPLEX WITH NOXA BH3 PEPTIDE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM TARGET HR2930 | BCL-2 FAMILY, STRUCTURAL GENOMICS, PSI-2, PROTEIN STRUCTURE INITIATIVE, NORTHEAST STRUCTURAL GENOMICS CONSORTIUM, NESG, APOPTOSIS
5fdo:C (LEU174) to (HIS320) MCL-1 COMPLEXED WITH SMALL MOLECULE INHIBITOR | MCL-1, INHIBITOR, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX
5fdo:D (GLU173) to (HIS320) MCL-1 COMPLEXED WITH SMALL MOLECULE INHIBITOR | MCL-1, INHIBITOR, APOPTOSIS-APOPTOSIS INHIBITOR COMPLEX
5jsn:A (ASN11) to (TYR202) BCL2-INHIBITOR COMPLEX | BCL-2, ANTIBCL2, COMPLEX, VIRAL PROTEIN-INHIBITOR COMPLEX